Non-targeted effects (NTE) such as bystander effects or genomic instability have been known for many years but their significance for radiotherapy or medical diagnostic radiology are far from clear. Central to the issue are reported differences in response of normal and tumour tissues to signals from directly irradiated cells. This review will discuss possible mechanisms and implications of these different responses and will then discuss possible new therapeutic avenues suggested by the analysis. Finally, the importance of NTE for diagnostic radiology and nuclear medicine which stems from the dominance of NTE in the low dose region of the dose response curve will be presented. Areas such as second cancer induction and microenvironment plasticity will be discussed. Soon after the first publications in recent times relating to lethal mutations, genomic instability, delayed death or bystander effects, now known collectively as nontargeted effects or NTE [1] [2] [3][4][5][6], there was controversy in the literature and many reports of failure to find these unexpected consequences in non-irradiated cells or progeny of irradiated cells [7][8][9]. The initial confusion resolved somewhat when it was realised that all cell types did not show these effects [10,11] and that experimental conditions needed to be carefully controlled [12]. Later papers showed how complex the generation of NTE is with roles for p53, [13][14][15][16] serotonin [17][18][19][20][21], TGF, ROS [25][26][27], cell cycle phase [28,29] and many other factors (for reviews, see [30,31]). However a broad division could be made depending on whether the cell line derived from a p53 mutant or null tumour cell like with low dose radioresistance (a wide shoulder / high ratio ) where NTE, at least in the form of bystander effects (BE), were not seen and p53 wild type, low dose radiosensitive cell lines (small shoulder, low ratio) where NTE were pronounced [32]. The particular situation of low dose hypersensitivity/induced radioresistance (HRS/IRR) was particularly interesting since it seemed to be an anomaly until it was found that the BE were expressed in the HRS part of the dose 
response curve but not after the dose response became IRR at higher doses [33, 34] .
These findings led to the generalisation that fast growing cell lines which demonstrated radioresistance in the low dose range such as HT29 or PC3 [34] were less likely to show BE than slower growing radiosensitivive cells such as HaCaT or SW48 [34] . Later studies with tissues confirmed that tumour derived explants and tumour bearing animals or animals with tumour susceptibility had less pronounced BE than normal tissues or animals [35] [36] [37] [38] . The situation with genomic instability (GI) was less clear mainly because endpoints for GI included events resulting in increased death of progeny, such as lethal mutation or delayed death frequency [30, 31] or gastrotrichus [39] but also included chromosomal instability endpoints where viable progeny were produced with increased potential for cancer development or transformation in vitro [40, 41] .
b. Possible reasons/mechanisms
Once the phenomenology of NTE became more fully documented, attention turned to the mechanisms which could allow non-irradiated cells and distant progeny of recovered irradiated cells to display essentially the same endpoints (see table 1 ).
Initially there was a focus on the use of separation techniques such as HPLC to try to determine the size and nature of the proposed molecule which caused NTE. These approaches proved unsuccessful. Attention turned to the response pathways which became the focus of mechanistic studies [42] . Cytokine activation was identified [43] and stress pathways downstream of ROS elevation were documented [44, 45] .
Apoptosis was found to be increased in the non-targeted cells [46] [47] [48] [49] , as were steps in the apoptotic pathway such as calcium flux, mitochondrial membrane depolarisation, caspase 3 release etc. [50] [51] [52] . DNA repair proficiency was also shown to be important with radiosensitive mutants (irrespective of the precise mutation) releasing stronger bystander signals than the wild type parents [53] [54] [55] [56] [57] .
This was later also shown in fish [58] . However, the nature of the signal from the irradiated cells remained a mystery. Breakthroughs came on two aspects of signal production in 2012 when it was shown that exosomes were released by irradiated shown that irradiation of organic matter (shells, fruits or cells) led to biophoton emission in the UVA range and that there seemed to be a physical component to the initial bystander signal [63] [64] [65] [66] . A series of papers [67] [68] [69] linked the photon emissions to the extent of the BE and implicated both p53 and exosomes in the mechanism. (see Figure 1) . The definitive experiments isolated exosomes and showed that exosomes from cells which received the UVA signal from irradiated cells without medium transfer, could by themselves produce a BE in never irradiated cells [69] . UVA alone was already known to produce BE from research in the 1990's [70, 71] . Another piece of the puzzle fell into place with the linking of the UVA biophotons to a block of the activity of mitochondrial complex 1 [72] . This leads to depletion of cellular ATP levels and is the type of global issue that could explain many of the reported consequences of low dose radiation exposure such as fatigue, reduced repair capacity and immune system compromise since these are all dependent of cellular energy availability [73, 74] . Complex one block has been associated in the literature with UVA exposure and ROS elevation [75] . Currently the race is on in many laboratories to profile exosomes in an attempt to further understand the mechanisms of transmission of bystander signals although the evidence referenced above suggests that biophotons may be sufficient by themselves to induce both BE and GI. Regarding GI the consensus is that this is driven at least in part by BE because GI can be triggered by bystander signals as well as by direct irradiation [76] and harvest of media from descendants of irradiated cells shows perpetuation of signal production in bystander cells [77] .
c. Discussion of relevance of smoking and other lifestyle factors
In addition to studying mechanisms associated with cellular genetic type, many studies have been done to look at the effects of environmental and lifestyle factors on the induction of NTE by radiation. These include the effects of heavy metals, organic pollutants, radium and tritium contamination, which confirm that both bystander signalling and GI can be modulated (usually increased) by concomitant exposure to a second stressor. In humans the smoking history and in vitro treatment of human cells and explants with smoking specific nitrosamines prior to irradiation have been studied using a human explant model [78, 79] . Radiation-induced BE was less toxic in terms of apoptosis induction in explanted tissues from smokers but that was associated with induction of anti-apoptotic proteins and suggests a procarcinogenesis rather than pro-apoptosis response to radiation in urothelium from smokers. Treatment of bladder urothelium from non-smokers with the specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), found in the urine of smokers, also induced this phenotype [80] .
Relevance for therapy: -possible approaches to enhance the therapeutic ratio a. Inhibition of NTE pathways in normal tissue
The paradox of NTE is that what may be good for an individual cell (e.g. not dying from the radiation dose) may be bad at the level of the population of cells or the organism, if living means carrying potentially carcinogenic damage. Also given that NTE are more prevalent in normal cells than in tumour cells, the adverse effects of NTE in radiotherapy could be considerable. This area has been considered in detail by those studying "out of field" effects [81, 82] . Reducing NTE in normal tissue is considered to be a potential novel target for improving radiotherapy outcomes.
Those working on the complex one block in mitochondria which is implicated in many non-radiation associated conditions such as chronic fatigue syndrome (CFS) have identified a number of places in the complex where specific activators or inhibitors of complex one could be targeted [83] . However the situation may not be as simple as that because there are many reports of NTE induced adaptive and protective responses acting at the population level [84, 85] and NTE are seen my some as a mechanism for coordinating normal tissue level response to harmful stimuli such as ionising radiation [86] [87] [88] . Clearly it would not be wise to block such a mechanism.
b. Stimulation of NTE pathways in tumour tissues
The corollary of blocking NTE in normal tissues would be to try to stimulate NTE in tumour cell populations. To our knowledge this approach has not been tried but could perhaps involve UVA/biophoton exposure concomitant with radiotherapy, or exposure to antioxidants during therapy to stimulate mitochondrial function.
Possibly if exosomes and their specific cargos could be harnessed they could activate NTE in tumours as well.
Relevance for diagnostic radiology

Relevance of low dose dominance of NTE
There are two obvious areas of interest here given the enormous increase in the use of radiation-associated techniques in diagnosis of disease [89] . There is considerable controversy about whether any harm is being caused by such tests (for reviews see [90] [91] [92] ). The NTE related concerns relate to the fact that NTE dominate the dose response at low doses and can triggered by acute exposures as low as 2-3mGy and increase until the NTE response saturates at about 0.5Gy at least in vitro [93] [94] [95] . There is no information about saturation or initiation doses in vivo or in humans but very early work by this group correlated low dose radiosensitivity (then reported in terms of survival curve shoulder width or n value) with the burden of delayed lethal mutations [96] [97] [98] . This suggests that a retrospective analysis of human derived cell lines, or samples where bystander signal information could be obtained, for example the human skin series [99] or the RERF (Radiation Effects research Foundation) blood samples from A-bomb survivors [100] might be interesting to correlate with the subsequent epidemiology. The two main NTE concerns are 2 nd cancer induction, and microenvironmental plasticity due to genomic instability.
a. 2 nd cancer induction
Cell transformation in vitro has been shown as an endpoint in non-targeted cells [100, 101] and modelling of bystander effect impacts on the cancer induction dose response using linear-non-threshold approaches [102] have suggested that NTE may increase the chances of second cancer induction. Further evidence for a potential role of NTE in 2 nd cancer induction after low dose exposures comes from early data in the literature showing persistent expression of clastogenic factors, micronuclei or microsatellite instability in distant progeny of those exposed or in blood of those exposed several years earlier [103] [104] [105] [106] . These data have been reviewed several times but not with respect to the possibility of NTE being involved in second cancer induction (for example [31] , [107] ).
b. Microenvironmental plasticity
This refers to the ability of the microenvironment to change in response to changes in the system [108] . There is considerable interest currently in what is termed "cross-talk" between functional units in organs and support tissues such as endothelium, fibrous tissue and components of blood and endocrine systems [109] .
Maintenance of a healthy microenvironment is critical to the control of function and to the abolition of pre-cancerous cells [110] . Induction of NTE signalling probably has multiple roles depending on other factors such as genetic or epigenetic makeup [111] , environmental or lifestyle factors [112] or age [113] , all of which can modulate the processes of NTE and the outcomes which may ultimately emerge. Key factors in defining the role of NTE in microenvironmental plasticity are the level at which the effects are of concern e.g. cell, organ, individual or population and the time over which adaptive or mal-adaptive instability has operated. The follow-up epidemiological studies on patients who have experienced low dose medical diagnostic exposure should be an important source of information in this regard.
Conclusion
This short review highlights areas in radiotherapy and diagnostic radiology where non-targeted effects of radiation may be important drivers of outcomes. Areas of most concern relate to the low dose induction of genomic instability and to modulation of normal radiation response pathways by altered signalling due to bystander effects. The importance of context (environmental stressors, lifestyle, age and genetic background are also discussed. Clearly these processes could be involved in determining outcomes after radiation exposure (diagnostic or therapeutic) and should probably be further considered in radiation medicine. Genetic Differences in Radiosensitivity Genetic Differences in Radiosensitivity *Persistent effects in descendant progeny that occur following no further irradiation and in cells neighbouring directly irradiated cells however never directly exposed themselves. 
